These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37253814)

  • 41. Toll-like receptor-6 (TLR6) deficient mice are protected from myocardial fibrosis induced by high fructose feeding through anti-oxidant and inflammatory signaling pathway.
    Zhang Y; Zhang Y
    Biochem Biophys Res Commun; 2016 Apr; 473(2):388-95. PubMed ID: 26940740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetes.
    Li Y; Ma J; Zhu H; Singh M; Hill D; Greer PA; Arnold JM; Abel ED; Peng T
    Diabetes; 2011 Nov; 60(11):2985-94. PubMed ID: 21911754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to bench.
    Chang WT; Cheng JT; Chen ZC
    Cardiovasc Diabetol; 2016 Aug; 15(1):113. PubMed ID: 27519769
    [TBL] [Abstract][Full Text] [Related]  

  • 44. GCN2 deficiency ameliorates cardiac dysfunction in diabetic mice by reducing lipotoxicity and oxidative stress.
    Feng W; Lei T; Wang Y; Feng R; Yuan J; Shen X; Wu Y; Gao J; Ding W; Lu Z
    Free Radic Biol Med; 2019 Jan; 130():128-139. PubMed ID: 30389499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy.
    Huynh K; McMullen JR; Julius TL; Tan JW; Love JE; Cemerlang N; Kiriazis H; Du XJ; Ritchie RH
    Diabetes; 2010 Jun; 59(6):1512-20. PubMed ID: 20215428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deletion of RasGRF1 Attenuated Interstitial Fibrosis in Streptozotocin-Induced Diabetic Cardiomyopathy in Mice through Affecting Inflammation and Oxidative Stress.
    Tsai TH; Lin CJ; Chua S; Chung SY; Chen SM; Lee CH; Hang CL
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30308936
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpressed connective tissue growth factor in cardiomyocytes attenuates left ventricular remodeling induced by angiotensin II perfusion.
    Zhang Y; Yan H; Guang GC; Deng ZR
    Clin Exp Hypertens; 2017; 39(2):168-174. PubMed ID: 28287886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes.
    Ritchie RH; Love JE; Huynh K; Bernardo BC; Henstridge DC; Kiriazis H; Tham YK; Sapra G; Qin C; Cemerlang N; Boey EJ; Jandeleit-Dahm K; Du XJ; McMullen JR
    Diabetologia; 2012 Dec; 55(12):3369-81. PubMed ID: 23001375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
    Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
    Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression.
    Bulani Y; Sharma SS
    Cardiovasc Drugs Ther; 2017 Jun; 31(3):255-267. PubMed ID: 28695302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.
    Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH
    Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy.
    Rajesh M; Bátkai S; Kechrid M; Mukhopadhyay P; Lee WS; Horváth B; Holovac E; Cinar R; Liaudet L; Mackie K; Haskó G; Pacher P
    Diabetes; 2012 Mar; 61(3):716-27. PubMed ID: 22315315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Attenuation of diabetes-induced cardiac inflammation and pathological remodeling by low-dose radiation.
    Zhang C; Jin S; Guo W; Li C; Li X; Rane MJ; Wang G; Cai L
    Radiat Res; 2011 Mar; 175(3):307-21. PubMed ID: 21388274
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monoamine oxidase-A is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy.
    Umbarkar P; Singh S; Arkat S; Bodhankar SL; Lohidasan S; Sitasawad SL
    Free Radic Biol Med; 2015 Oct; 87():263-73. PubMed ID: 26122707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats.
    Yu W; Wu J; Cai F; Xiang J; Zha W; Fan D; Guo S; Ming Z; Liu C
    PLoS One; 2012; 7(12):e52013. PubMed ID: 23251674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics.
    Jakubik D; Fitas A; Eyileten C; Jarosz-Popek J; Nowak A; Czajka P; Wicik Z; Sourij H; Siller-Matula JM; De Rosa S; Postula M
    Cardiovasc Diabetol; 2021 Feb; 20(1):55. PubMed ID: 33639953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tempol ameliorates cardiac fibrosis in streptozotocin-induced diabetic rats: role of oxidative stress in diabetic cardiomyopathy.
    Taye A; Abouzied MM; Mohafez OM
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec; 386(12):1071-80. PubMed ID: 23949118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Understanding One Half of the Sex Difference Equation: The Modulatory Effects of Testosterone on Diabetic Cardiomyopathy.
    Visanji M; Venegas-Pino DE; Werstuck GH
    Am J Pathol; 2024 Apr; 194(4):551-561. PubMed ID: 38061627
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current challenges in the treatment of cardiac fibrosis: Recent insights into the sex-specific differences of glucose-lowering therapies on the diabetic heart: IUPHAR Review 33.
    Sharma A; De Blasio M; Ritchie R
    Br J Pharmacol; 2023 Nov; 180(22):2916-2933. PubMed ID: 35174479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function.
    Bernardo BC; Yildiz GS; Kiriazis H; Harmawan CA; Tai CMK; Ritchie RH; McMullen JR
    Cells; 2022 Oct; 11(19):. PubMed ID: 36231079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.